相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 技术资料
- 保存条件:
Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- CAS号:
115066-04-1
- 规格:
1 mg/5 mg/10 mg/25 mg/50 mg/100 mg
| 规格: | 1 mg | 产品价格: | ¥340.0 |
|---|---|---|---|
| 规格: | 5 mg | 产品价格: | ¥750.0 |
| 规格: | 10 mg | 产品价格: | ¥1300.0 |
| 规格: | 25 mg | 产品价格: | ¥2500.0 |
| 规格: | 50 mg | 产品价格: | ¥4000.0 |
| 规格: | 100 mg | 产品价格: | ¥6000.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
α-NETA
CAS No. : 115066-04-1
MCE 国际站:α-NETA
产品活性:α-NETA 是一种有效的,非竞争性的胆碱乙酰转移酶 (ChA) 抑制剂,IC50 为 9 μM。α-NETA 是一种有效的 ALDH1A1 (IC50=0.04 µM) 和趋化因子样受体 1 (CMKLR1) 拮抗剂。α-NETA 微弱的抑制胆碱酯酶 (ChE; IC50=84 µM) 和乙酰胆碱酯 (AChE; IC50=300 µM)。α-NETA 具有抗癌活性。
研究领域:Metabolic Enzyme/Protease | Neuronal Signaling | Apoptosis
作用靶点:Aldehyde Dehydrogenase (ALDH) | Cholinesterase (ChE) | Apoptosis
In Vitro: α-NETA (50-150 nM; 24 hours) decreases all cell lines viability in a dose-dependent manner.
?α-NETA (2.5-10.0 μg/mL; 24 hours) leads to epithelial ovarian cancer (EOC) cell death associated with membrane blistering and cytoplasm leakage.
?α-NETA treatment increases EOC cell expression of pyroptosis-associated proteins.
?α-NETA is most potent in inhibiting aldehyde dehydrogenase 1 family, member A1 (ALDH1A1; IC50=0.04 μM; purified enzymes assay), followed by CMKLR1 (IC50=0.375 μM for β-ARR2 recruitment; Cell-based assay) and G9a histone lysine methyltransferase (IC50=0.50 μM; purified enzymes assay). α-NETA selectively inhibits chemerin-stimulated CMKLR1 association with β-arrestin2.
?α-NETA possesses fluorescent characteristics (excitation spectrum: maxima 255 and 297 nm; emission spectrum: maximum 437 nm) of naphthyl moiety.
In Vivo: α-NETA (i.p.; 0.125 mg/kg; once every other day for 20 days) significantly decreases tumor volume and tumor weight.
?α-NETA (s.c. injection; 3 mg/kg or 10 mg/kg; daily; for 30 days) significantly delays the onset of EAE with 3 mg/kg, and completely suppresses clinical signs for an average of nine days with 10 mg/kg beyond the first appearance of disease in control female C57BL/6 mice.
相关产品:Bioactive Compound Library Plus | Apoptosis Compound Library | Metabolism/Protease Compound Library | Neuronal Signaling Compound Library | Anti-Cancer Compound Library | Glutamine Metabolism Compound Library | Anti-Cancer Metabolism Compound Library | Targeted Diversity Library | Cancer Stem Cells Compound Library | Membrane Protein-targeted Compound Library | Cell Death Library | MG-132 | Doxorubicin hydrochloride | Bafilomycin A1 | LY294002 | Tamoxifen | Paclitaxel | Y-27632 | Acetylcysteine | Angiotensin II human | 2-Deoxy-D-glucose | Staurosporine | SB-431542 | Actinomycin D | Deferoxamine mesylate | Bortezomib | 5-Fluorouracil | Trametinib | Sorafenib | Oxaliplatin | Gemcitabine | Temozolomide | Rotenone | Mdivi-1 | Elesclomol | Ruxolitinib | Decitabine | SP600125 | MK-2206 dihydrochloride | Etoposide | Monomethyl auristatin E
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料

















